FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2008551421> ?p ?o ?g. }

• W2008551421 abstract "Positron-emission tomographic (PET) studies and genetic research of stuttering have recently revealed underlying cerebral neurobiologic contributing factors in this disorder. We aimed to assess whether cognitive impairment and other neuropsychiatric dimensions could be detected through computerized content analysis of short samples of speech from stutterers, and whether administration of risperidone in a double-blind placebo-controlled study could decrease the severity of stuttering, as well as any of the neuropsychiatric features of these stutterers. A group of 21 stutterers with the developmental form of stuttering, an onset before age of 6 years, aged 20 to 74 years, and who were otherwise free of major medical or psychiatric problems, initially gave a 5-minute tape-recorded speech sample in response to purposely ambiguous instructions to talk about any interesting or dramatic life experiences. Then, half of these subjects (n = 10) were randomly selected to receive 6 weeks of risperidone treatment up to 2.0 mg/d and the other half (n = 11) were administered a placebo. Both groups of subjects gave a second verbal sample after 6 weeks of treatment. Significantly elevated cognitive impairment and social alienation-personal disorganization scores, derived from the computerized content of the initial 5-minute speech samples, were found. After 6 weeks, the risperidone group improved significantly on a measure of severity of stuttering but did not improve on the percentage of time spent stuttering. The placebo group did not improve on either measure of stuttering. The psychopathological processes of subjects who received risperidone treatment, including those with elevated cognitive impairment and social alienation-personal disorganization, did not change significantly. However, stutterers who had lower scores on verbal content analysis-derived shame anxiety, guilt anxiety, or hostility inward measures improved significantly more with risperidone than stutterers with higher scores on these measures. The findings of elevated cognitive impairment and social alienation-personal disorganization scores of adult stutterers with the early developmental form of stuttering are consistent with the neurobiologic abnormalities found in PET-scan and genetic research involving stutterers. Risperidone (< or =2.0 mg/d) can reduce the severity of stuttering while not significantly affecting the magnitude of neuropsychiatric dimensions such as cognitive impairment or social alienation-personal disorganization. The less the inward shame, guilt, or hostility of the stutterers, the better the beneficial effect of risperidone on the severity of stuttering." @default.
• W2008551421 created "2016-06-24" @default.
• W2008551421 creator A5028087155 @default.
• W2008551421 creator A5037354000 @default.
• W2008551421 creator A5052470572 @default.
• W2008551421 creator A5060903707 @default.
• W2008551421 creator A5074624430 @default.
• W2008551421 creator A5091143840 @default.
• W2008551421 date "1999-07-01" @default.
• W2008551421 modified "2023-09-27" @default.
• W2008551421 title "Stuttering: Neuropsychiatric features measured by content analysis of speech and the effect of risperidone on stuttering severity" @default.
• W2008551421 cites W118706593 @default.
• W2008551421 cites W1516813895 @default.
• W2008551421 cites W1518767068 @default.
• W2008551421 cites W153750880 @default.
• W2008551421 cites W181926014 @default.
• W2008551421 cites W1939248712 @default.
• W2008551421 cites W1968335983 @default.
• W2008551421 cites W1976275497 @default.
• W2008551421 cites W1979303942 @default.
• W2008551421 cites W1979488156 @default.
• W2008551421 cites W1987915353 @default.
• W2008551421 cites W1990003238 @default.
• W2008551421 cites W1994286302 @default.
• W2008551421 cites W2003204755 @default.
• W2008551421 cites W2008753085 @default.
• W2008551421 cites W2039903483 @default.
• W2008551421 cites W2040797442 @default.
• W2008551421 cites W2042898927 @default.
• W2008551421 cites W2052703823 @default.
• W2008551421 cites W2059649308 @default.
• W2008551421 cites W2068760272 @default.
• W2008551421 cites W2110395878 @default.
• W2008551421 cites W2131318153 @default.
• W2008551421 cites W2133693044 @default.
• W2008551421 cites W2166659155 @default.
• W2008551421 cites W2210906546 @default.
• W2008551421 cites W2397903832 @default.
• W2008551421 cites W2411125875 @default.
• W2008551421 cites W2495529659 @default.
• W2008551421 cites W3134626641 @default.
• W2008551421 cites W608271567 @default.
• W2008551421 cites W611972048 @default.
• W2008551421 doi "https://doi.org/10.1016/s0010-440x(99)90132-3" @default.
• W2008551421 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10428191" @default.
• W2008551421 hasPublicationYear "1999" @default.
• W2008551421 type Work @default.
• W2008551421 sameAs 2008551421 @default.
• W2008551421 citedByCount "18" @default.
• W2008551421 countsByYear W20085514212012 @default.
• W2008551421 countsByYear W20085514212014 @default.
• W2008551421 crossrefType "journal-article" @default.
• W2008551421 hasAuthorship W2008551421A5028087155 @default.
• W2008551421 hasAuthorship W2008551421A5037354000 @default.
• W2008551421 hasAuthorship W2008551421A5052470572 @default.
• W2008551421 hasAuthorship W2008551421A5060903707 @default.
• W2008551421 hasAuthorship W2008551421A5074624430 @default.
• W2008551421 hasAuthorship W2008551421A5091143840 @default.
• W2008551421 hasConcept C118552586 @default.
• W2008551421 hasConcept C123273963 @default.
• W2008551421 hasConcept C138496976 @default.
• W2008551421 hasConcept C14216870 @default.
• W2008551421 hasConcept C142724271 @default.
• W2008551421 hasConcept C15744967 @default.
• W2008551421 hasConcept C169900460 @default.
• W2008551421 hasConcept C204787440 @default.
• W2008551421 hasConcept C27081682 @default.
• W2008551421 hasConcept C2776412080 @default.
• W2008551421 hasConcept C2780057945 @default.
• W2008551421 hasConcept C2781371259 @default.
• W2008551421 hasConcept C548259974 @default.
• W2008551421 hasConcept C70410870 @default.
• W2008551421 hasConcept C71924100 @default.
• W2008551421 hasConceptScore W2008551421C118552586 @default.
• W2008551421 hasConceptScore W2008551421C123273963 @default.
• W2008551421 hasConceptScore W2008551421C138496976 @default.
• W2008551421 hasConceptScore W2008551421C14216870 @default.
• W2008551421 hasConceptScore W2008551421C142724271 @default.
• W2008551421 hasConceptScore W2008551421C15744967 @default.
• W2008551421 hasConceptScore W2008551421C169900460 @default.
• W2008551421 hasConceptScore W2008551421C204787440 @default.
• W2008551421 hasConceptScore W2008551421C27081682 @default.
• W2008551421 hasConceptScore W2008551421C2776412080 @default.
• W2008551421 hasConceptScore W2008551421C2780057945 @default.
• W2008551421 hasConceptScore W2008551421C2781371259 @default.
• W2008551421 hasConceptScore W2008551421C548259974 @default.
• W2008551421 hasConceptScore W2008551421C70410870 @default.
• W2008551421 hasConceptScore W2008551421C71924100 @default.
• W2008551421 hasLocation W20085514211 @default.
• W2008551421 hasLocation W20085514212 @default.
• W2008551421 hasOpenAccess W2008551421 @default.
• W2008551421 hasPrimaryLocation W20085514211 @default.
• W2008551421 hasRelatedWork W1979303942 @default.
• W2008551421 hasRelatedWork W1981949629 @default.
• W2008551421 hasRelatedWork W1996398362 @default.
• W2008551421 hasRelatedWork W2051812300 @default.
• W2008551421 hasRelatedWork W2051817607 @default.
• W2008551421 hasRelatedWork W2052152483 @default.
• W2008551421 hasRelatedWork W205548380 @default.
• W2008551421 hasRelatedWork W2061372946 @default.

• next